Showing results (241-250 of 269) with videos related to
Sort By:
Pageof 27
Archives of Pharmacal Research|February 26, 2013
A new phenanthrene derivative and two diarylheptanoids from the roots of Brassica rapa ssp. campestris inhibit the growth of cancer cell lines and LDL-oxidationQian Wu, Jin-Gyeong Cho, Ki-Hyun Yoo, et al.Frontiers in Pharmacology|May 9, 2022
Mosloflavone-Resveratrol Hybrid TMS-HDMF-5z Exhibits Potent <i>In Vitro</i> and <i>In Vivo</i> Anti-Inflammatory Effects Through NF-κB, AP-1, and JAK/STAT InactivationSeo-Yeon Kim, Ahmed H E Hassan, Kyung-Sook Chung, et al.Molecular Brain|September 12, 2020
Altered presynaptic function and number of mitochondria in the medial prefrontal cortex of adult Cyfip2 heterozygous miceGyu Hyun Kim, Yinhua Zhang, Hyae Rim Kang, et al.Journal of Microbiology and Biotechnology|September 10, 2018
High-Level Production of High-Purity Human and Murine Recombinant Prion Proteins Functionally Compatible to In Vitro Seeding AssayHae-Gwang Hwang, Dae-Hwan Kim, Jeongmin Lee, et al.Journal of Medicinal Chemistry|December 13, 2007
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analoguesHyungChul Ryu, Mi-Kyoung Jin, Su Yeon Kim, et al.Journal of Neurochemistry|May 14, 2022
Protein interactome and cell-type expression analyses reveal that cytoplasmic FMR1-interacting protein 1 (CYFIP1), but not CYFIP2, associates with astrocytic focal adhesionRuiying Ma, Kaifang Pang, Hyojin Kang, et al.Bioorganic & Medicinal Chemistry|February 26, 2004
Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 bindingJeewoo Lee, Su Yeon Kim, Soyoung Park, et al.EMBO Molecular Medicine|July 24, 2012
Hypoxic priming of mESCs accelerates vascular-lineage differentiation through HIF1-mediated inverse regulation of Oct4 and VEGFSae-Won Lee, Han-Kyul Jeong, Ji-Young Lee, et al.Biochemical Pharmacology|January 22, 2026
Gut microbiota-derived isoxanthohumol metabolite, 8-prenylnaringenin, mitigates endothelial dysfunction in Angiotensin II-induced hypertension through G protein-coupled estrogen receptor-mediated eNOS activationSeung Yeon Lee, Anh Thi Ngoc Bui, Tuyet Ngan Thai, et al.Cancer Research and Treatment|March 14, 2023
Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal CancerDae-Won Lee, Yoojoo Lim, Hwang-Phill Kim, et al.Pageof 27